Aptyx, a contract development and manufacturing organization (CDMO) for the life sciences industry, has acquired Argos Corporation, a precision extrusion company with expertise and technologies across materials and manufacturing processes.

Thanks to this deal, Aptyx will combine its growing precision extrusion portfolio and launch a Precision Extrusion Center of Excellence. This adds immediate capacity, enhanced capabilities, and in-house engineering expertise for interventional innovation, the company said.

“This marks another milestone in our growth strategy, further enhancing our ability to provide integrated expertise and innovation for our OEM Life Science customers,” said Aptyx president and CEO Gregg Tobin. “This new center perfectly complements our Interventional Center of Excellence in Charlotte, where we have a long history of supporting complex transcatheter implants and delivery systems from early design to finished device manufacturing.”

The new Precision Extrusion Center of Excellence expands the scale, technology, and catheter-grade precision to support development and manufacturing of complex interventional systems. The Center’s capabilities include high-precision tubing with wall thicknesses from .001” and ID/OD tolerances to .0005”, as well as quick-turn development and manufacturing in a controlled environment.

In-house tooling design will support speed, precision, and risk mitigation. The Center will also boast a broad range of materials and capabilities including multi-lumen, precise taper tubing, micro extrusions, co-extrusion, multi-layered extrusion, and balloon tubing.

The new facility adds depth to Aptyx’s portfolio of capabilities—including molding, extrusion, coating solutions, and finished device assembly—to enhance its integrated design and manufacturing platform.

“We’re committed to conquering technical challenges and advancing what’s possible in medical tubing,” said Patrick Daly, Aptyx’s director of Global Extrusion. “This expansion deepens our extrusion expertise and enhances how we bring specialized strengths together across Aptyx to drive medtech advancement.”